Abstract:Mycobacterium tuberculosis ( M. tb ) is one of the most successful human pathogens, causing a severe and widespread infectious disease. The frequent emergence of multidrug-resistant (MDR) strains has exacerbated this public health crisis, particularly in underdeveloped regions. M. tb employs a sophisticated array of virulence factors to subvert host immune responses, both innate and adaptive. It utilizes the early secretory antigenic target (ESAT6) secretion system 1 (ESX-1) type VII secretion system (T7SS) and cell wall lipids to disrupt phagosomal integrity, inhibiting phagosome maturation, and fusion with lysosomes. Although host cells activate mechanisms such as ubiquitin (Ub), Ub-ligase, and cyclic GMP-AMP synthase-stimulator of interferon genes 1 (CGAS-STING1)-mediated autophagy to inhibit M. tb survival within macrophages, the pathogen counteracts these defenses with its own virulence factors, thereby inhibiting autophagy and dampening host-directed responses. T7SSs are critical for transporting proteins across the complex mycobacterial cell envelope, performing essential functions, including metabolite uptake, immune evasion, and conjugation. T7SS substrates fall into two main families: ESAT-6 system proteins, which are found in both Firmicutes and Actinobacteria, and proline-glutamic acid (PE) and proline-proline-glutamic acid (PPE) proteins, which are unique to mycobacteria. Recent studies have highlighted the significance of T7SSs in mycobacterial growth, virulence, and pathogenesis. Understanding the mechanisms governing T7SSs could pave the way for novel therapeutic strategies to combat mycobacterial diseases, including tuberculosis (TB). T7SS of M. tb plays a critical role in the bacterium's virulence, pathogenesis, and survival within host cells. T7SS mediates the secretion of PE-PPE proteins and ESX substrates, which are pivotal in various cellular processes. These include damaging the phagosome, inducing ubiquitination, autophagy, and promoting the release dsDNA. Furthermore, T7SS activates key immune responses such as inflammasome formation, CGAS-STING1 signaling, and type I IFN production, while stimulating the secretion of proinflammatory cytokines. It also contributes to inflammation, necroptosis, pyroptosis, and facilitates the dissemination of M. tb to neighboring cells. In addition to promoting immune responses, T7SS is involved in nutrient acquisition and inhibits host cell defense mechanisms. It prevents phagosome-lysosome fusion, impairs phagosome repair mechanisms, and inhibits phagosome maturation, enabling M. tb to survive within macrophages. Targeting multiple stages of the T7SS pathway offers potential therapeutic strategies to inhibit its function, thereby reducing M. tb replication, virulence, and pathogenicity, as highlighted in the accompanying figure through cross-marks. These insights provide promising avenues for the development of interventions aimed at disrupting the T7SS and mitigating M. tb infection. AR = autophagy receptors (SQSTM1/p62, NBR1, CALCOCO2, TAX1BP1, OPTN, TRIM16, and TRIM32).

Mycobacterium tuberculosis VII secretion system effector molecule Rv2347c blocks the maturation of phagosomes and activates the STING/TBK1 signaling pathway to inhibit cell autophagy

M. tb Rv0927c suppresses the activation of HIF-1α pathway through VHL-mediated ubiquitination and NF-κB/COX-2 pathway to enhance mycobacteria survival

Mycobacterium tuberculosis Rv1043c regulates the inflammatory response by inhibiting the phosphorylation of TAK1

Mycobacterium Tuberculosis Rv0426c Promotes Recombinant Mycobacteria Intracellular Survival Via Manipulating Host Inflammatory Cytokines and Suppressing Cell Apoptosis.

A Mycobacterium Tuberculosis Surface Protein Recruits Ubiquitin to Trigger Host Xenophagy

Mycobacterium Tuberculosis Rv0790c Inhibits the Cellular Autophagy at Its Early Stage and Facilitates Mycobacterial Survival

Mycobacterium Tuberculosis Rv0928 Protein Facilitates Macrophage Control of Mycobacterium Infection by Promoting Mitochondrial Intrinsic Apoptosis and ROS-mediated Inflammation

Mycobacterium tuberculosis Rv0927c Inhibits NF-κB Pathway by Downregulating the Phosphorylation Level of IκBα and Enhances Mycobacterial Survival

Mycobacterium tuberculosis protein Rv2652c enhances intracellular survival by inhibiting host immune responses

Mycobacterium Tuberculosis Rv1515c Antigen Enhances Survival of M. Smegmatis Within Macrophages by Disrupting the Host Defence.

Mycobacterium tuberculosis Rv3435c regulates inflammatory cytokines and promotes the intracellular survival of recombinant Mycobacteria

Mycobacterium Tuberculosis Rv3402c Enhances Mycobacterial Survival Within Macrophages and Modulates the Host Pro-Inflammatory Cytokines Production Via NF-kappa B/ERK/p38 Signaling.

Mycobacterial Rv1804c Binds to the PEST Domain of IκBα and Activates Macrophage-Mediated Proinflammatory Responses

Mycobacterium Tuberculosis Serine Protease Rv3668c Can Manipulate the Host-Pathogen Interaction Via Erk-NF-κB Axis-Mediated Cytokine Differential Expression.

Mycobacterium tuberculosis Rv0341 Promotes Mycobacterium Survival in In Vitro Hostile Environments and within Macrophages and Induces Cytokines Expression

Secreted Rv1768 From RD14 of Mycobacterium tuberculosis Activates Macrophages and Induces a Strong IFN-γ-Releasing of CD4 + T Cells.

Rv3722c Promotes Mycobacterium tuberculosis Survival in Macrophages by Interacting With TRAF3

Mycobacterium Tuberculosis Rv0580c Impedes the Intracellular Survival of Recombinant Mycobacteria, Manipulates the Cytokines, and Induces ER Stress and Apoptosis in Host Macrophages Via NF-κB and P38/jnk Signaling

Mechanisms of immune evasion by Mycobacterium tuberculosis: the impact of T7SS and cell wall lipids on host defenses

Recombinant Lipoprotein Rv1016c Derived from Mycobacterium Tuberculosis is a TLR-2 Ligand That Induces Macrophages Apoptosis and Inhibits MHC II Antigen Processing

Mycobacterium tuberculosis MmsA (Rv0753c) Interacts with STING and Blunts the Type I Interferon Response